October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...
Maryland residents can expect above-average treatment and survival rates for lung cancer, according to an American Lung ...
Last month, IceCure Medical’s tumor-freezing technology won FDA approval for treating early-stage breast cancer. Now, the Israel-based medtech is touting a new study showing its procedure combined ...
More than 28% of lung cancers were detected early, when survival rates are better — a 12% improvement over five years. Also, ...
A groundbreaking advancement in lung cancer diagnosis is happening right here in Acadiana. A new robotic system is making ...
By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at ...
At first, Young was hesitant to take advantage, preferring to give priority to her elderly patients who "don't get the ...
Iowa has the second-highest cancer rate in the U.S., and a new report shows its lung cancer cases exceed the U.S. national ...
A new mobile lung cancer screening unit from Ohio State University Comprehensive Cancer Center – The James aims to meet ...
Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...
ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results